(DEA) to be registered as a bulk Drug Schedule Dated: September 21, 2007.
manufacturer of the basic classes of Joseph T. Rannazzisi, controlled substances listed in schedule Phenylacetone (8501) .................. II Deputy Assistant Administrator, Office of I and II: Raw Opium (9600) ....................... II Diversion Control, Drug Enforcement Concentrate of Poppy Straw II Administration. (9670). [FR Doc. E7–19100 Filed 9–26–07; 8:45 am] Drug Schedule BILLING CODE 4410–09–P The company plans to import the Tetrahydrocannabinols (7370) ..... I listed controlled substances to Dihydromorphine (9145) ............... I DEPARTMENT OF JUSTICE Dihydrocodeine (9120) ................. II manufacture bulk controlled substances Oxycodone (9143) ........................ II for sale to its customers. Drug Enforcement Administration Hydromorphone (9150) ................ II No comments, objections, or requests Hydrocodone (9193) ..................... II for any hearings will be accepted on any Manufacturer of Controlled Sufentanil (9740) .......................... II Fentanyl (9801) ............................ II application for registration or re- Substances; Notice of Application Remifentanil (9739) ...................... II registration to import crude opium, Pursuant to § 1301.33(a) of Title 21 of [Raw Opium (9600)], poppy straw, the Code of Federal Regulations (CFR), The company plans to manufacture concentrate of poppy straw, and coca this is notice that on August 24, 2007, the listed controlled substances in bulk leaves. ISP Freetown Fine Chemicals, 238 for distribution to its customers. Any bulk manufacturer who is Any other such applicant and any South Main Street, Assonet, presently, or is applying to be, Massachusetts 02702, made application person who is presently registered with DEA to manufacture such a substance registered with DEA to manufacture by renewal to the Drug Enforcement may file comments or objections to the such basic classes of controlled Administration (DEA) to be registered as issuance of the proposed registration substances listed in schedule I or II, a bulk manufacturer of the basic classes pursuant to 21 CFR 1301.33(a). which fall under the authority of section of controlled substances listed in Any such written comments or 1002(a)(2)(B) of the Act (21 U.S.C. schedule I and II: objections being sent via regular mail 952(a)(2)(B) may, in the circumstances should be addressed, in quintuplicate, set forth in 21 U.S.C. 958(i), file Drug Schedule to the Drug Enforcement comments or objections to the issuance 2,5-Dimethoxyamphetamine I Administration, Office of Diversion of the proposed registration and may, at (7396). Control, Federal Register Representative the same time, file a written request for Amphetamine (1100) .................... II (ODL), Washington, DC 20537, or any a hearing on such application pursuant Phenylacetone (8501) .................. II being sent via express mail should be to 21 CFR 1301.43 and in such form as sent to Drug Enforcement prescribed by 21 CFR 1316.47. The company plans to manufacture Administration, Office of Diversion Phenylacetone to be used in the Control, Federal Register Representative Any such comments or objections being sent via regular mail should be manufacture of Amphetamine for (ODL), 2401 Jefferson Davis Highway, distribution to its customers. The bulk Alexandria, Virginia 22301; and must be addressed, in quintuplicate, to the Drug 2,5-Dimethoxyamphetamine will be filed no later than November 26, 2007. Enforcement Administration, Office of used for conversion into non-controlled Diversion Control, Federal Register Dated: September 21, 2007. substances. Representative (ODL), Washington, DC Joseph T. Rannazzisi, Any other such applicant and any 20537, or any being sent via express Deputy Assistant Administrator, Office of person who is presently registered with mail should be sent to Drug DEA to manufacture such a substance Diversion Control, Drug Enforcement Administration. Enforcement Administration, Office of may file comments or objections to the [FR Doc. E7–19099 Filed 9–26–07; 8:45 am] Diversion Control, Federal Register issuance of the proposed registration Representative (ODL), 2401 Jefferson pursuant to 21 CFR 1301.33(a). BILLING CODE 4410–09–P Davis Highway, Alexandria, Virginia Any such written comments or 22301; and must be filed no later than objections being sent via regular mail DEPARTMENT OF JUSTICE October 29, 2007. should be addressed, in quintuplicate, This procedure is to be conducted to the Drug Enforcement Drug Enforcement Administration simultaneously with, and independent Administration, Office of Diversion Importer of Controlled Substances; of, the procedures described in 21 CFR Control, Federal Register Representative Notice of Application 1301.34(b), (c), (d), (e) and (f). As noted (ODL), Washington, DC 20537, or any in a previous notice published in the being sent via express mail should be Pursuant to Title 21 Code of Federal Federal Register on September 23, 1975, sent to Drug Enforcement Regulations 1301.34(a), this is notice (40 FR 43745–46), all applicants for Administration, Office of Diversion that on August 30, 2007, Chattem registration to import a basic class of Control, Federal Register Representative Chemicals, Inc., 3801 St. Elmo Avenue, any controlled substances in schedule I (ODL), 2401 Jefferson Davis Highway, Building 18, Chattanooga, Tennessee or II are and will continue to be required Alexandria, Virginia 22301; and must be 37409, made application by renewal to to demonstrate to the Deputy Assistant filed no later than November 26, 2007. the Drug Enforcement Administration Administrator, Office of Diversion Dated: September 21, 2007. (DEA) for registration as an importer of Control, Drug Enforcement Joseph T. Rannazzisi, rwilkins on PROD1PC63 with NOTICES
the basic classes of controlled
Administration, that the requirements Deputy Assistant Administrator, Office of substances listed in schedule II: for such registration pursuant to 21 Diversion Control, Drug Enforcement U.S.C. 958(a); 21 U.S.C. 823(a); and 21 Administration. Drug Schedule CFR 1301.34(b), (c), (d), (e) and (f) are [FR Doc. E7–19131 Filed 9–26–07; 8:45 am] Methamphetamine (1105) ............ II satisfied. BILLING CODE 4410–09–P